Eledon to present kidney transplant trial outcomes for tegoprubart at ASN Kidney Week

Eledon Pharmaceuticals Inc. will present new patient-reported outcomes from its Phase 2 BESTOW kidney-transplant trial of tegoprubart versus tacrolimus on Oct. 23, 2026, at ASN Kidney Week in Denver.